Feb 10, 2026 07:03AM
Feb 10, 2026 07:00AM
Jan 27, 2026 08:00AM
Nov 16, 2025 03:00PM
Oct 28, 2025 07:02AM
Oct 28, 2025 07:00AM
Oct 8, 2025 08:00AM Incyte to Report Third Quarter Financial Results
Aug 5, 2025 04:05PM
Aug 5, 2025 04:05PM
Jul 30, 2025 08:29AM
Jul 29, 2025 07:02AM
Jul 29, 2025 07:00AM
Jul 15, 2025 09:44AM
Jul 10, 2025 08:00AM Incyte to Report Second Quarter Financial Results
Jun 16, 2025 03:09AM
Jun 15, 2025 04:00AM
Apr 29, 2025 07:00AM
Apr 29, 2025 07:00AM
Apr 10, 2025 08:00AM
Feb 10, 2025 07:10AM
Feb 10, 2025 07:00AM Incyte Reports 2024 Fourth Quarter and Year-End Financial Results, Provides 2025 Financial Guidance and Highlights 2025 R&D Milestones
Jan 21, 2025 08:00AM
Oct 30, 2024 06:26AM
Oct 29, 2024 07:03AM
Oct 29, 2024 07:00AM
Oct 8, 2024 08:00AM
Jul 30, 2024 07:03AM
Jul 30, 2024 07:00AM Incyte Reports 2024 Second Quarter Financial Results and Provides Updates on Key Clinical Programs
Jul 9, 2024 08:00AM
Apr 30, 2024 07:03AM
Apr 30, 2024 07:00AM
Apr 11, 2024 08:00AM
Feb 14, 2024 03:42AM
Feb 13, 2024 07:13AM
Feb 13, 2024 07:00AM Incyte Reports 2023 Fourth Quarter and Year-End Financial Results, Provides 2024 Financial Guidance and Highlights R&D Priorities
Jan 23, 2024 08:00AM
Jan 8, 2024 08:31AM
Jan 8, 2024 08:30AM
Oct 31, 2023 07:00AM
Oct 31, 2023 07:00AM
Oct 10, 2023 08:14AM
Oct 10, 2023 08:00AM Incyte to Report Third Quarter Financial Results
Aug 1, 2023 07:04AM
Aug 1, 2023 07:00AM
Jul 11, 2023 08:00AM
May 2, 2023 09:12AM
May 2, 2023 07:00AM
Apr 11, 2023 08:00AM
Feb 7, 2023 07:04AM Incyte (INCY) Tops Q4 EPS by 32c
Feb 7, 2023 07:00AM

1,168,522 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All